Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab.

Autor: Rivera, Fernando1 oncrhf@humv.es, Vega-Villegas, Ma Eugenia1, Lopez-Brea, Marta F.1, Marquez, Raul1
Zdroj: Acta Oncologica. Jan2008, Vol. 47 Issue 1, p9-19. 11p. 4 Charts.
Databáze: Academic Search Ultimate